FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is using 5α-androstane -3β,5,6β-triol for preparing neuroprotective drugs.
EFFECT: compound possesses the significant protective action against neuronal injuries caused by cerebral ischemia, spinal ischemia or hypoxia, and has no noticeable toxic reactions within its effective dose.
4 cl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
NEUROPROTECTIVE AGENTS AND THEIR APPLICATION | 2015 |
|
RU2672264C2 |
2(,3(,5(-TRIHYDROXY-ANDROST-6-ONE, METHODS FOR ITS PRODUCTION AND APPLICATION | 2014 |
|
RU2629929C2 |
INJECTABLE FORM OF 5α ANDROSTANE-3β,5,6β-TRIOL AND METHOD FOR PREPARING IT | 2011 |
|
RU2532354C1 |
AGENT WITH NEUROPROTECTIVE ANTI-ISCHEMIC ACTIVITY | 2022 |
|
RU2780112C1 |
NEUROPROTECTIVE PHARMACEUTICAL AGENT | 2013 |
|
RU2528914C1 |
NEUROPROTECTIVE AGENT | 2016 |
|
RU2614697C1 |
PHARMACEUTICAL COMBINATION INCLUDING EPIDERMAL GROWTH FACTOR AND GHRP6 PEPTIDE AS A SECRETION STIMULATOR FOR RECOVERY AFTER BRAIN DAMAGE | 2019 |
|
RU2776812C1 |
ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
PHARMACOLOGICAL NEUROPROTECTIVE DRUG | 2014 |
|
RU2561045C1 |
METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
Authors
Dates
2015-02-10—Published
2011-07-08—Filed